CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA /ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes? Coronary flow velocity reserve predicts adverse prognosis in women with angina and noobstructive coronary artery disease: resultsfrom the iPOWER study Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Effect of Aspirin on All-Cause Mortality in the Healthy Elderly Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions 稳定性冠心病诊断与治疗指南 Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock
|<<... 54 55 56 57 58 59 60 ...>>|

Original Research2011 Feb 1;4(1):9-14.

JOURNAL：Circ Cardiovasc Interv. Article Link

Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis

Kang SJ, Mintz GS, Park DW et al. Keywords: luminal loss; drug-eluting stent; morphology; in-stent restenosis; restenoisis

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top